Eveline Annette van de Stadt (E A van de Stadt)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

EJNMMI research

Diagnostics (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Imke H Bartelink, Eveline Annette van de Stadt, A F Leeuwerik, Victor L J L Thijssen, J R I Hupsel, J F van den Nieuwendijk, I Bahce, M Yaqub, N H Hendrikse
Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict PET Image Quality of Three Generations EGFR TKI in Advanced-Stage NSCLC Patients. Pharmaceuticals (Basel, Switzerland) 15 (7) (2022)
Eveline Annette van de Stadt, Maqsood Yaqub, Robert C Schuit, Imke H Bartelink, Anke F Leeuwerik, Lothar A Schwarte, Adrianus J de Langen, Harry Hendrikse, Idris Bahce
Relationship between Biodistribution and Tracer Kinetics of 11 C-Erlotinib, 18 F-Afatinib and 11 C-Osimertinib and Image Quality Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis in Advanced Stage Non-Small Cell Lung Cancer Patients. Diagnostics (Basel, Switzerland) 12 (4) (2022)
Eveline Annette van de Stadt, M Yaqub, A A Lammertsma, A J Poot, P R Schober, R C Schuit, E F Smit, I Bahce, N H Hendrikse
Quantification of [18F]afatinib using PET/CT in NSCLC patients: a feasibility study. EJNMMI research 10 (1) (2020)